Early Prenatal Detection of Mutation of Dystrophin Gene in Patients With Duchenne Muscular Dystrophy

被引:0
|
作者
Abdrakhmanova, Zh U. [1 ]
Mahambetov, K. O. [1 ]
Abildinova, G. Zh [1 ]
机构
[1] Astana Med Univ, 49A Baybitshilik Str, Astana, Kazakhstan
关键词
Duchenne muscular dystrophy; the mutation boundaries in the dystrophin gene; the spectra of the deletions in the dystrophin gene; the method of pre-clinical diagnostics for predicting mutations;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
As far as at this current stage in practical healthcare there is actual problem we have necessity to search for new ways of early detection of hereditary diseases and identification of precise mutation borders. An article is considered the multiplex ligation-dependent probe amplification (MLPA) making it possible to expand the search for mutation boundaries and predict the probability of birth of an unhealthy child which was developed according to our research. The developed method of pre-clinical diagnostics for predicting mutations in the dystrophin gene in its heterozygous state in pre- and postnatal periods is allowed to identify "hot spots" of break between exons 45-50 of DMD gene.
引用
收藏
页码:2056 / 2061
页数:6
相关论文
共 50 条
  • [31] Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
    Frank, Diane E.
    Schnell, Frederick J.
    Akana, Cody
    El-Husayni, Saleh H.
    Desjardins, Cody A.
    Morgan, Jennifer
    Charleston, Jay S.
    Sardone, Valentina
    Domingos, Joana
    Dickson, George
    Straub, Volker
    Guglieri, Michela
    Mercuri, Eugenio
    Servais, Laurent
    Muntoni, Francesco
    NEUROLOGY, 2020, 94 (21) : E2270 - E2282
  • [32] Novel 3698delA mutation in Exon 26 of the dystrophin gene causing Duchenne muscular dystrophy
    Agarwal-Mawal, A
    Vanasse, M
    Simard, LR
    HUMAN MUTATION, 1998, : S23 - S24
  • [33] Detection of deletions within the dystrophin gene in Polish families affected with Duchenne/Becker muscular dystrophy
    Zimowski, JG
    Bisko, MU
    Fidzianska, EJ
    Fidzianska, AZ
    Badurska, B
    NiebrojDobosz, I
    Kozlowska, M
    HausmanowaPetrusewicz, I
    Zaremba, JS
    EUROPEAN JOURNAL OF NEUROLOGY, 1997, 4 (02) : 138 - 142
  • [34] Re-engineering dystrophin for gene therapy of Duchenne muscular dystrophy
    van Raamsdonk, J
    CLINICAL GENETICS, 2002, 62 (01) : 25 - 27
  • [35] Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophy
    A Ferrer
    K E Wells
    D J Wells
    Gene Therapy, 2000, 7 : 1439 - 1446
  • [36] Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?
    Gorecki, Dariusz C.
    Kalinski, Pawel
    Pomeroy, Joanna
    GENE THERAPY, 2025,
  • [37] Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy
    Jacqueline N. Robinson-Hamm
    Charles A. Gersbach
    Human Genetics, 2016, 135 : 1029 - 1040
  • [38] Immune responses to dystrophin: implications for gene therapy of Duchenne muscular dystrophy
    Ferrer, A
    Wells, KE
    Wells, DJ
    GENE THERAPY, 2000, 7 (17) : 1439 - 1446
  • [39] Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy
    Robinson-Hamm, Jacqueline N.
    Gersbach, Charles A.
    HUMAN GENETICS, 2016, 135 (09) : 1029 - 1040
  • [40] Full-length dystrophin gene therapy for Duchenne muscular dystrophy
    Duan, Dongsheng
    MOLECULAR THERAPY, 2024, 32 (09) : 2817 - 2818